Express Scripts Holding Co. shares were halted in the extended session Monday after the pharmacy-benefits manager’s earnings topped Wall Street estimates for the quarter, raised their outlook, and said insurer Anthem Inc. does not intend to renew a contract when it expires. Express Scripts shares were halted at $67.25 after hours, following a 1.2% gain on the regular session. The company reported adjusted first-quarter earnings of $1.33 a share on revenue of $24.65 billion. Analysts surveyed by FactSet had estimated earnings of $1.32 a share on revenue of $25 billion. For the year, Express Scripts sees earnings of $6.90 to $7.04 a share, up from its previous forecast range of $6.82 to $7.02 a share. Analysts expect earnings of $6.93 a share. Express Scripts also said Anthem does not intend to renew a services contact with the company when it expires at the end of 2019 but has not received official notice of the decision. The company said Anthem accounted for $15.15 billion out of 2015’s $101.75 billion in revenue.
Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.
From:: Stock Market News